| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.079 | 0.06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |